Light-activated antibodies in the fight against primary and metastatic cancer
Authors:
- Alexander C. SelfASAlexander C. Self
- Colin H. SelfCSColin H. Self
- 1 June 2010
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 15 (11-12) , 468-473
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Light-Directed Activation of Human T-CellsChemMedChem, 2007
- Light Activation of Anti-CD3 in vivo Reduces the Growth of an Aggressive Ovarian CarcinomaChemMedChem, 2007
- Immunonanoshells for targeted photothermal ablation in medulloblastoma and glioma: an in vitro evaluation using human cell linesJournal of Neuro-Oncology, 2007
- The Construction of a Functional Photoactivatable Cancer Targeting Bispecific Antibody ConjugateChemMedChem, 2007
- A bispecific diabody directed against prostate-specific membrane antigen and CD3 induces T-cell mediated lysis of prostate cancer cellsCancer Immunology, Immunotherapy, 2007
- Recombinant therapeutic antibodiesApplied Microbiology and Biotechnology, 2007
- Potent inhibition of local and disseminated tumor growth in immunocompetent mouse models by a bispecific antibody construct specific for Murine CD3Cancer Immunology, Immunotherapy, 2005
- Selective Photothermal Interaction Using an 805-nm Diode Laser and Indocyanine Green in Gel Phantom and Chicken Breast TissueLasers in Medical Science, 2002
- Isolated Limb Perfusion in the Management of Patients With Recurrent Limb Melanoma: An Important but Limited RoleAnnals of Surgical Oncology, 2001
- Photocleavable Nitrobenzyl-Protein ConjugatesBiochemical and Biophysical Research Communications, 1994